Concepedia

Thomas J. Hudzik

TJ

31

Publications

781

Citations

17

H-Index

1992

Active since

Affiliations

AstraZeneca (United States)(Current)

University of Arkansas for Medical Sciences

AbbVie (United States)

Wilmington University

Memorial University of Newfoundland

Thomas J. Hudzik is an author at AstraZeneca (United States) specializing in medicine, pharmacology, and neuroscience.

ORCID

Top concepts

Publications per year

1992–2021

31

Publications

31

A randomized, placebo-controlled pilot trial of the delta opioid receptor agonist AZD2327 in anxious depression

Erica M. Richards, Daniel C. Mathews, David A. Luckenbaugh et al. · Psychopharmacology · 2016 · 70 citations · Full text

, , +10

Effects of drugs of abuse and cholinergic agents on delayed matching-to-sample responding in the squirrel monkey.

Thomas J. Hudzik, Galen R. Wenger · Journal of Pharmacology and Experimental Therapeutics · 1993 · 58 citations

Preclinical Pharmacology of AZD2327: A Highly Selective Agonist of the δ-Opioid Receptor

Thomas J. Hudzik, Carla Maciag, Mark A. Smith et al. · Journal of Pharmacology and Experimental Therapeutics · 2011 · 54 citations

Long-Term Functional End Points Following Middle Cerebral Artery Occlusion in the Rat

Thomas J. Hudzik, A R Borrelli, Paul Bialobok et al. · Pharmacology Biochemistry and Behavior · 2000 · 51 citations

, , +13

T<sub>2</sub>‐Weighted MRI Correlates with Long‐Term Histopathology, Neurology Scores, and Skilled Motor Behavior in a Rat Stroke Model

Gene C. Palmer, James Peeling, Dale Corbett et al. · Annals of the New York Academy of Sciences · 2001 · 48 citations

, , +26

Rows per page

1–5 of 31